Deep Intelligent Pharma at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Deep Intelligent Pharma takes part in 1 session at BIO-Europe 2026 in Cologne. Its session sets out a doctor-to-doctor pathway into Japan built on investigator-initiated trials, using AI and decentralized clinical trials to reach Japanese patients faster. Deep Intelligent Pharma also sponsors the meeting.

OrganizationBIO-Europe 2026 Attendance
◆Platinum Sponsor
dipgroup.com/en
Tools, data & AIPlatinum sponsor
AI company offering AI-powered clinical development services and software, from protocol design and data management to regulatory documents.
Talk
Mon Nov 9
09:00–10:00
Doctor-to-Doctor: A PI-Led Pathway into Japan Using AI, DCT, and Registration-Directed Investigator-Initiated Trials to Reach Japanese Patients Faster
How trials led by the right Japanese doctor, rather than a contract research company, can take a drug toward approval in Japan.
Clinical StrategyRegulatory Strategy

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Deep Intelligent Pharma

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction